SARS Cov-2 Immune Response in Health Care Workers - is There Need for Antibody Titer Testing in Post Vaccinated Individuals
Authors/Creators
- 1. Associate Professor, Department of Biochemistry, CDSIMER, Ramanagara, Karnataka, India
- 2. Associate Professor, Department of Biochemistry, Dr. Moopens Medical College, Wayanad, Kerala, India
- 3. Assistant Professor, Department of Biochemistry, ESIC Dental College, Kalaburagi, Karnataka, India
- 4. Assistant Professor, Department of Biochemistry, CDSIMER, Ramanagara, Karnataka, India
- 5. Professor, Department of Biochemistry, CDSIMER, Ramanagara, Karnataka, India
Description
Background: Studying the immune response among health care workers in different areas is crucial for understanding the risk and vaccine deployment. Our study was designed to measure the immune response in post vaccinated health care workers and evaluate the immune response with type of vaccination. So that it can help in better management of the disease. Methodology: SARS CoV-2 IgG-II levels were measured in health care workers post vaccinated with covishield and covaxin, also the effect of covid positivity on antibody response. Results: Compared to males females had significant increase in reactivity (p=0.0227) with Median value of reactivity among males was 9.96 AU/mL[ 7.31-12.31] and of females was 5.4 AU/mL[0.53-14.77]. Median value of 12.035 AU/mL[6.11-74.9] in vaccinated was significantly increased (p=0.0008) compared to median value of 1.28 AU/mL[0.52-6.43] in non-vaccinated health care workers. Significant difference [p= <0.0001] as observed covid positive health care workers as compared to covid negative with median values of 59.4 Au/mL[47.56-167] and 6.11 Au/mL[0.54-11.96]. Vaccinated and non-vaccinated health care workers tested positive for covid are had median reactivity of 231.7 AU/mL[49.03-168.56] and 9.98 AU/mL [5.27-14.69] respectively. covid negative health care workers, vaccinated had median value of reactivity of 7.37 AU/mL[5.34-18.28] as compared to 1.27 Au/mL[0.45-4.03] in non-vaccinated [p=0.0131]. Conclusion: Seroprevalence among the health care workers has a varied response. State of covid positivity, vaccination, type of vaccination and infection along with vaccination affect the Antibody response. Thus measuring the immune response will guide us in taking precautions and better management of the disease.
Abstract (English)
Background: Studying the immune response among health care workers in different areas is crucial for understanding the risk and vaccine deployment. Our study was designed to measure the immune response in post vaccinated health care workers and evaluate the immune response with type of vaccination. So that it can help in better management of the disease. Methodology: SARS CoV-2 IgG-II levels were measured in health care workers post vaccinated with covishield and covaxin, also the effect of covid positivity on antibody response. Results: Compared to males females had significant increase in reactivity (p=0.0227) with Median value of reactivity among males was 9.96 AU/mL[ 7.31-12.31] and of females was 5.4 AU/mL[0.53-14.77]. Median value of 12.035 AU/mL[6.11-74.9] in vaccinated was significantly increased (p=0.0008) compared to median value of 1.28 AU/mL[0.52-6.43] in non-vaccinated health care workers. Significant difference [p= <0.0001] as observed covid positive health care workers as compared to covid negative with median values of 59.4 Au/mL[47.56-167] and 6.11 Au/mL[0.54-11.96]. Vaccinated and non-vaccinated health care workers tested positive for covid are had median reactivity of 231.7 AU/mL[49.03-168.56] and 9.98 AU/mL [5.27-14.69] respectively. covid negative health care workers, vaccinated had median value of reactivity of 7.37 AU/mL[5.34-18.28] as compared to 1.27 Au/mL[0.45-4.03] in non-vaccinated [p=0.0131]. Conclusion: Seroprevalence among the health care workers has a varied response. State of covid positivity, vaccination, type of vaccination and infection along with vaccination affect the Antibody response. Thus measuring the immune response will guide us in taking precautions and better management of the disease.
Files
IJPCR,Vol14,Issue10,Article86.pdf
Files
(393.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:92325b4bc0ad42be2d1489805c426bd0
|
393.3 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-10-10
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/14/IJPCR,Vol14,Issue10,Article86.pdf
- Development Status
- Active
References
- 1. Worldometer: coronavirus update. [Jan;2021];https://www.worldometers.i nfo/coronavirus/ 2019 2. Profile of immunoglobulin G and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Qu J, Wu C, Li X, et al. Clin Infect Dis. 2020;71:2255– 2258. 3. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Azkur AK, Akdis M, Azkur D, et al. Allergy. 2020;75:1564–1581. - 4. Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. New England Journal of Medicine. 2020;383(27):2603–2615. 5. 3. Omer SB, Yildirim I, Forman HP. Herd Immunity and Implications for SARS-CoV-2 Control. JAMA. 2020;324(20):2095–2096. 6. Murhekar MV, Bhatnagar T, Thangaraj JW, Saravanakumar V, Santhosh Kumar M, Selvaraju S, Rade K, Kumar CG, Sabarinathan R, Asthana S, Balachandar R.Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional study. PLoS medicine. 2021 Dec 10;18(12):e1003877. 7. Chidananda MK, Zohmangaihi D, Ram S, Soni SL, Suri V, Malhotra P, Jassal RS, Kaur J, Verma I, Sharma S. Combined Analysis of Anti SARSCoV-2 IgG and IgM Responses in COVID19 Patients in India. Indian Journal of Clinical Biochemistry. 2021 Oct;36(4):485-91. 8. Zhang S, Xu K, Li C, Zhou L, Kong X, Peng J, Zhu F, Bao C, Jin H, Gao Q, Zhao X. Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV2 Antibodies Based on a COVID-19 Patients Cohort. Frontiers in immunology. 2022 Jan 27; 13:829665. 9. Imai K, Kitagawa Y, Tabata S, Kubota K, Nagura-Ikeda M, Matsuoka M, Miyoshi K, Sakai J, Ishibashi N, Tarumoto N, Takeuchi S. Antibody response patterns in COVID-19 patients with different levels of disease severity in Japan. Journal of medical virology. 2021 May;93(5):3211-8. 10. Dundar B, Karahangil K, Elgormus CS, Topsakal HN. Efficacy of antibody response following the vaccination of SARS-CoV-2 infected and noninfected healthcare workers by two-dose inactive vaccine against COVID-19. Journal of medical virology. 2022 Jun;94(6):2431-7. 11. IJ O., BU O., & SO N. Prevalence of Post-Operative Anaemia and its Complications among Obstetric and Gynaecological Patients in Enugu. Journal of Medical Research and Health Sciences, 2022; 5(9): 2250– 2255.